Mats Bergström

16.5k total citations
271 papers, 8.9k citations indexed

About

Mats Bergström is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Epidemiology. According to data from OpenAlex, Mats Bergström has authored 271 papers receiving a total of 8.9k indexed citations (citations by other indexed papers that have themselves been cited), including 119 papers in Radiology, Nuclear Medicine and Imaging, 40 papers in Molecular Biology and 40 papers in Epidemiology. Recurrent topics in Mats Bergström's work include Medical Imaging Techniques and Applications (92 papers), Radiopharmaceutical Chemistry and Applications (35 papers) and Cancer, Hypoxia, and Metabolism (26 papers). Mats Bergström is often cited by papers focused on Medical Imaging Techniques and Applications (92 papers), Radiopharmaceutical Chemistry and Applications (35 papers) and Cancer, Hypoxia, and Metabolism (26 papers). Mats Bergström collaborates with scholars based in Sweden, United States and Japan. Mats Bergström's co-authors include Bengt Långström, E. Hultman, T. Greitz, G. Blomqvist, Bengt Långström, K. Ericson, Anders Sundin, Anders Lilja, Kjell Öberg and J. Litton and has published in prestigious journals such as Journal of Clinical Oncology, NeuroImage and Analytical Chemistry.

In The Last Decade

Mats Bergström

265 papers receiving 8.5k citations

Peers

Countries citing papers authored by Mats Bergström

Since Specialization

Citations

This map shows the geographic impact of Mats Bergström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mats Bergström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mats Bergström more than expected).

Fields of papers citing papers by Mats Bergström

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mats Bergström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mats Bergström. The network helps show where Mats Bergström may publish in the future.

Co-authorship network of co-authors of Mats Bergström

This figure shows the co-authorship network connecting the top 25 collaborators of Mats Bergström. A scholar is included among the top collaborators of Mats Bergström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mats Bergström. Mats Bergström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CD64 as novel molecular imaging marker for the characterization of synovitis in rheumatoid arthritis 2023 ·Arthritis Research & Therapy ·(unknown), Irene Di Ceglie, (unknown), Arjen B. Blom, Desirée L. Bos, Thomas Vogl, Sander W. Tas, (unknown), Mats Bergström, (unknown), P.M. van der Kraan, Peter Laverman, Marije I. Koenders, P.L. van Lent, Martijn H. J. van den Bosch	5
2	The biodistribution and clearance of AlbudAb, a novel biopharmaceutical medicine platform, assessed via PET imaging in humans 2019 ·EJNMMI Research ·Kevin S. Thorneloe, Armin Sepp, Sean X. Zhang, (unknown), (unknown), Wasfi Al‐Azzam, Daniëlle J. Vugts, Guus A.M.S. van Dongen, (unknown), (unknown), Andor W.J.M. Glaudemans, (unknown), (unknown), (unknown), Mary Birchler, (unknown), Mats Bergström, Marie Davies	16
3	The Use of Microdosing in the Development of Small Organic and Protein Therapeutics 2017 ·Journal of Nuclear Medicine ·Mats Bergström	17
4	Molecular imaging in oncology drug development 2016 ·Drug Discovery Today ·Sarah R. Mudd, Robert A. Comley, Mats Bergström, Kyle D. Holen, Yanping Luo, (unknown), Gerard B. Fox, Laurent Martarello, John D. Beaver	11
5	Biodistribution of ⁶⁸ Ga-Labeled LNA–DNA Mixmer Antisense Oligonucleotides for Rat Chromogranin-A 2008 ·Oligonucleotides ·Gábor Lendvai, Irina Velikyan, Sergio Estrada, Barbro Eriksson, Bengt Långström, Mats Bergström	23
6	Increase in [11C]vorozole binding to aromatase in the hypothalamus in rats treated with anabolic androgenic steroids 2007 ·Neuroreport ·Kayo Takahashi, Mathias Hallberg, Kristina Magnusson, Fred Nyberg, Yasuyoshi Watanabe, Bengt Långström, Mats Bergström	17
7	Imaging of aromatase distribution in rat and rhesus monkey brains with [11C]vorozole 2006 ·Nuclear Medicine and Biology ·Kayo Takahashi, Mats Bergström, (unknown), (unknown), Yasuyoshi Watanabe, Bengt Långström	40
8	[¹¹C]Metomidate Positron Emission Tomography of Adrenocortical Tumors in Correlation with Histopathological Findings 2006 ·The Journal of Clinical Endocrinology & Metabolism ·Joakim Hennings, Örjan Lindhe, Mats Bergström, Bengt Långström, Anders Sundin, Per Hellman	90
9	Performance of PCA and ICA with respect to signal extraction from noisy PET data : a study on computer simulated images 2005 ·(unknown), (unknown), H. Schneider, Bengt Långström, Ewert Bengtsson, Mats Bergström	1
10	Pharmacokinetic studies with PET 2005 ·Birkhäuser-Verlag eBooks ·Mats Bergström, Bengt Långström	11
11	Effects of 2-ME on proliferation, apoptosis and PET-tracer uptake in human prostate cancer cell aggregates 2004 ·Nuclear Medicine and Biology ·Padideh Davoodpour, Mats Bergström, Maréne Landström	1
12	Mechanisms of basal and cytokine-induced uptake of glucose in normal human eosinophils: relation to apoptosis 2003 ·Respiratory Medicine ·Per Venge, (unknown), E. Björnsson, Mats Bergström, Bengt Långström, Lena Håkansson	14
13	In vitro and in vivo primate evaluation of carbon-11-etomidate and carbon-11-metomidate as potential tracers for PET imaging of the adrenal cortex and its tumors. 1998 ·PubMed ·Mats Bergström, Thomas A. Bonasera, Frank Leigh Lu, (unknown), Carin Backlin, Claes Juhlin, Bengt Långström	74
14	Positron emission tomography (PET) with 5-hydroxytryptophan (5-HTP) in the diagnosis and treatment follow upp of carcinoid tumors 1998 ·Journal of Clinical Oncology ·Håkan Örlefors, Anders Sundín, Anders Lilja, Mats Bergström, Håkan Åhlström, Bengt Långström, Kjell Öberg, Barbro Eriksson	10
15	Synthesis, In Vivo Rhesus Monkey Biodistribution and In Vitro Evaluation of a 11C-Labelled Potent Aromatase Inhibitor: [N-methyl-11C]Vorozole 1998 ·Nuclear Medicine and Biology ·Pelle Lidström, Thomas A. Bonasera, (unknown), Bo Lindblom, Frank Leigh Lu, (unknown), Mats Bergström, Jan‐Erik Westlin, Bengt Långström	26
16	Modulation of organ uptake of 11C-5-hydroxytryptophan. 1996 ·Mats Bergström, (unknown), Barbro Eriksson, (unknown), Bengt Långström	7
17	Catechol-O-Methyltransferase Inhibition Increases the Uptake of¹¹C-3-(3,4-Dihydroxyphenyl)-L-Alanine in the Rat Pancreas 1996 ·Scandinavian Journal of Gastroenterology ·Mats Bergström, (unknown), Marcela Márquez, Robert Moulder, Gunilla Jacobsson, Mattias Ögren, Barbro Eriksson, Yasuyoshi Watanabe, Bengt Långström	3
18	Gadolinium-Enhanced MRI and Positron Emission Tomography in Bell’s palsy: A Preliminary Report 1994 ·PubMed ·Mathias Engström, Lars Jönsson, K.-Å. Thuomas, Anders Lilja, Mats Bergström	1
19	Positron‐Emission Tomography as a Radiological Technique in Neuroendocrine Gastrointestinal Tumors 1994 ·Annals of the New York Academy of Sciences ·Barbro Eriksson, Anders Lilja, Håkan Åhlström, Peter Bjurling, Mats Bergström, Karl‐Johan Lindner, Bengt Långström, Kjell Öberg	8
20	Positron Emission Tomography (PET) in Neuroendocrine Gastrointestinal Tumors 1993 ·Acta Oncologica ·Barbro Eriksson, Mats Bergström, Anders Lilja, Håkan Åhlström, Bengt Långström, Kjell Öberg	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact